According to Xenon Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -3,26ย โฌ. In 2024 the company made an earnings per share (EPS) of -2,53ย โฌ a decrease over its 2023 EPS that were of -2,28ย โฌ.